Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestationsJan‐Niklas Eckardt, Jan Moritz Middeke, Hermann Einsele et al.|Journal of Hematology & Oncology|2022Cited by 58
Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligenceJan‐Niklas Eckardt, Jan Moritz Middeke, Waldemar Hahn et al.|npj Digital Medicine|2024Cited by 58
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learningJan‐Niklas Eckardt, Jan Moritz Middeke, Christoph Röllig et al.|Haematologica|2022Cited by 47
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classificationJan‐Niklas Eckardt, Christoph Röllig, Marius Bill et al.|Leukemia|2023Cited by 36
Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcomeJan‐Niklas Eckardt, Christian Thiede, Sebastian Stasik et al.|Blood Cancer Journal|2023Cited by 34